Found 5 matching trials
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
PHASE1The study is an open-label phase I/II clinical trial. The study will enroll...
Location
Washington University School of Medicine
Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma
PHASE2This is a multicenter study comprising two phases: a run-in phase, includin...
Location
Multiple Locations
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
PHASE1The investigational drug to be studied in this protocol, BCA101, is a first...
Location
Moores Cancer Center UC San Diego Health
Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC
PHASE2This trial is to evaluate the safety and efficacy of ficerafusp alfa in com...
Location
Brigham and Women's Hospital
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
PHASE2Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Re...